Susan Bates (@susanebates)

Susan Bates @susanebates Oct 30, 2025

Which scale most accurately measured distress in this study?

karan jatwani @jatwanikaran Oct 30, 2025

🚨 What is Distress in Cancer Care? 🚨
Cancer Distress 😟 is psychological/social/spiritual pain. 1 in 4 (20%)-->up to 80% impacted. Screen it! 🩺 The 6th Vital Sign!
#DistressScreening #PallOnc #TOeJC
doi.org/10.1200/OP.23.…

View quoted post on X

Susan Bates @susanebates Oct 30, 2025

This is our first ever OUP eJournal Club! We are anxious to ehear your thoughts on this study.

Cristiane D Bergerot, PhD, FASCO Verified account @crisbergerot Oct 30, 2025

@realbowtiedoc @lindacarlson @ASCO @Integrativeonc Absolutely agree — mindfulness-based interventions like #MBCR have shown meaningful benefits for people with cancer. Expanding access, particularly in #LMICs, remains a crucial next step. #TOeJC @OncJournal
@Linda_E_Carlson @AmDTx_official
View quoted post on X

Susan Bates @susanebates Apr 22, 2023

Upfront Atezolizumab Poses Lower Risk of Hyperprogression in NSCLC cancertherapyadvisor.com/home/cancer-to…

Susan Bates @susanebates Apr 21, 2023

Agree completely. Words matter, and "fail treatment" inevitably implies, however unintended, that the patient is somehow at fault. @OncJournal

Susan Bates @susanebates Mar 1, 2023

I am amazed & thrilled to have been selected for this important award, and am looking forward to being in Paris for the 2023 ESMO TAT meeting -- by my count it is TAT #20. Thank you ESMO! #ESMOTAT23

ESMO - Eur. Oncology Verified account @myESMO Feb 8, 2023

#ESMOTAT23: ESMO is pleased to announce that @susanebates received the 2023 ESMO TAT Honorary Award for her significant contribution to the field of anticancer drug development.
📌esmo.org/newsroom/esmo-…

View quoted post on X

Susan Bates

Latest posts 5